FMIP, a novel Fms-interacting protein, affects granulocyte/macrophage differentiation

Citation
T. Tamura et al., FMIP, a novel Fms-interacting protein, affects granulocyte/macrophage differentiation, ONCOGENE, 18(47), 1999, pp. 6488-6495
Citations number
27
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ONCOGENE
ISSN journal
09509232 → ACNP
Volume
18
Issue
47
Year of publication
1999
Pages
6488 - 6495
Database
ISI
SICI code
0950-9232(19991111)18:47<6488:FANFPA>2.0.ZU;2-V
Abstract
Hematopoietic cell growth, differentiation, and commitment to a restricted lineage are guided by a set of cytokines acting exclusively on cells expres sing the corresponding cytokine receptor. The macrophage colony stimulating factor (M-CSF, also termed CSF-1) and its cognate receptor, the tyrosine k inase c-Fms, are essential for monocyte and macrophage development. The und erlying molecular mechanism, however, is poorly understood. Here we identif ied a novel Fms-interacting protein (FMIP, MW 78 kDa) which binds transient ly via its N-terminal 144 residues to the cytoplasmic domain of activated F ms-molecules. Binding of FMIP was paralleled by rapid tyrosine phosphorylat ion within the binding domain which drastically reduced its ability to asso ciate with Fms. Binding was specific as evidenced by co-immunoprecipitation and association with recombinant GST-Fms fusion proteins. No binding was o bserved with the tyrosine phosphorylated cytoplasmic domains of c-Kit, TrkA , c-Met, and the insulin receptor. The role of FMIP in hematopoietic differ entiation was studied in the bipotential myeloid progenitor cell line, FDC- P1Mac11. Overexpression of FMIP prevented M-CSF induced macrophage differen tiation. Instead, cells differentiated into granulocytes. Our data suggest that the level of FMIP expression could form a threshold that decides about differentiation either into macrophages or into granulocytes.